Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
- 26 January 2004
- Vol. 22 (21-22), 2936-2942
- https://doi.org/10.1016/j.vaccine.2003.11.059
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Human Papillomavirus Testing for Triage of Women With Cytologic Evidence of Low-Grade Squamous Intraepithelial Lesions: Baseline Data From a Randomized TrialJNCI Journal of the National Cancer Institute, 2000
- Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical CancerNew England Journal of Medicine, 1999
- Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective studyThe Lancet, 1999
- Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: Correlation with virus-like particle IgG concentrationJournal of Medical Virology, 1997
- Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisaeGene, 1996
- Monoclonal Antibodies to HPV-6 L1 Virus-like Particles Identify Conformational and Linear Neutralizing Epitopes on HPV-11 in Addition to Type-Specific Epitopes on HPV-6Virology, 1996
- Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical DysplasiaJNCI Journal of the National Cancer Institute, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formationVaccine, 1995
- Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particlesVirology, 1991